The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 5.00 (2.70%)
Spread: 10.00 (5.405%)
Open: 185.00
High: 192.50
Low: 185.00
Prev. Close: 185.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Alliance

8 Dec 2005 08:23

Synexus Clinical Research PLC08 December 2005 Synexus Clinical Research plc ("Synexus") Forms Strategic Alliance with ICRI Research (P) Ltd. ("IRL") to establish India's first patient-recruitment Site Management Organisation (SMO) Synexus Clinical Research plc, the provider of clinical trials services to theglobal pharmaceutical industry, has entered into a strategic alliance with theIndian Clinical Research Institute, through the latter's Mumbai-based subsidiaryIRL. IRL-Synexus will establish a chain of fully owned GCP-compliant investigatorsites (IRL-Synexus Clinical Research Centres) across India, and the first hasnow been formally opened in Mumbai. All patients will be recruited throughinternationally accepted methods and the first patient is expected to berecruited to a trial in the first three months of 2006. Under the terms of the agreement, IRL's full-time GCP trained clinical researchteam are further trained by Synexus in UK, to ensure full implementation inIndia of Synexus' operating procedures. Synexus will continue to support andmonitor the centres in India to ensure compliance with these procedures. Synexus recently listed on AIM, with the declared strategy of replicating,through acquisitions and partnerships, its successful UK operations across arange of countries important to its clients for running clinical trials. TheIRL-Synexus alliance is the first of these strategic steps. Commenting on the collaboration, Dr Ian Smith, Medical Director of Synexus,said: "India possesses tremendous potential to become a preferred location forresearch and development for the global biotechnology and pharmaceutical sector.I am delighted that Synexus has formed an alliance with IRL, whose core valuesof expertise, proficiency and training blend perfectly with our systematic andeffective approach." Press enquiries Synexus Clinical Research plc Tel: +44 (0)1257 230 723Michael Redmond, Executive ChairmanDr Ian Smith, Medical Director Biddicks Tel: +44 (0)20 7448 1000Zoe Biddick NOTES TO EDITORS Synexus Clinical Research plc was formed in 1998 and is the largest patientrecruitment organisation in Europe. Synexus undertakes clinical trials servicesfor the global pharmaceutical industry, managing patients on clinical trials onbehalf of pharmaceutical companies and contract research organisations. Synexussources patient, assesses them for suitability through a screening process,manages the patients on the trials and collates data before reporting back toits client. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jul 20208:22 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSInterim Results
25th Jun 20209:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSMajor Contract Win and Notice of Interim Results
22nd May 20207:00 amRNSContract Wins with Long Term Customers
23rd Apr 202011:49 amRNSResult of AGM
23rd Apr 20207:00 amRNSBusiness Update
6th Apr 202012:24 pmRNSRevised Arrangements for Annual General Meeting
2nd Apr 20209:11 amRNSDirector/PDMR Shareholding
23rd Mar 20202:28 pmRNSBusiness Update: COVID-19
23rd Mar 20201:48 pmRNSAvailability of Report and Accounts and AGM
11th Mar 20204:23 pmRNSDirector/PDMR Shareholding
11th Mar 202012:11 pmRNSHolding(s) in Company
6th Mar 20201:59 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSSettlement of Legal Claim
25th Feb 20207:00 amRNSFinal Results
11th Feb 20204:12 pmRNSHolding(s) in Company
7th Feb 20202:33 pmRNSHolding(s) in Company
7th Feb 202010:43 amRNSReplacement - Holding(s) in Company
7th Feb 20207:00 amRNSNotification of Final Results
6th Feb 20204:58 pmRNSHolding(s) in Company
30th Jan 202012:17 pmRNSReplacement - Holding(s) in Company
28th Jan 20208:58 amRNSHolding(s) in Company
23rd Jan 20209:55 amRNSDirectorate Changes
13th Dec 201912:00 pmRNSDirectorate Change
21st Nov 20198:42 amRNSChange of Registered Office
5th Nov 20198:51 amRNSHolding(s) in Company
30th Oct 201911:06 amRNSSecond Price Monitoring Extn
30th Oct 201911:00 amRNSPrice Monitoring Extension
30th Oct 20197:00 amRNSTrading Update
2nd Oct 20194:12 pmRNSDirector/PDMR Shareholding
23rd Jul 20198:31 amRNSContract Win
23rd Jul 20197:00 amRNSHalf-year Report
21st Jun 20198:16 amRNSNotification of Interim Results
17th Jun 20199:53 amRNSHolding(s) in Company
13th Jun 20198:36 amRNSChange of Adviser
4th Jun 20191:41 pmRNSHolding(s) in Company
23rd May 201912:45 pmRNSDirector/PDMR Shareholding
25th Apr 20197:40 amRNSAGM Statement
24th Apr 20191:00 pmRNSDirector/PDMR Shareholding
27th Mar 20198:32 amRNSExercise of Options and Director/PDMR dealings
26th Mar 20197:00 amRNSContract Win in Gaming Sector
25th Mar 201910:01 amRNSDirectorate Change
21st Mar 201912:09 pmRNSAnnual Report and AGM
21st Mar 20197:00 amRNSOil & Gas Contract Win
8th Mar 20193:59 pmRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
25th Feb 20193:17 pmRNSHolding(s) in Company
19th Feb 20193:48 pmRNSDirectorate Update
29th Jan 20197:00 amRNSNotification of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.